Video from AACC: Highlights of Day 3
Highlights from the (sister site of team for Day 3 of the American Association for Clinical Chemistry (AACC) 2022 Chicago meeting. Read More
Video from AACC: Thermo Fisher CMO on the future of diagnostics
Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with's sister site to discuss shifts in the diagnostic testing landscape. Read More
Video from AACC: BrightInsight's Connected Diagnostics Platform
BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four tools: Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals. Read More
Video from AACC: Lab Ordering Cloud software
Mehdi Maghsoodnia, CEO of 1health, spoke to's sister site about the market needs for the firm’s Lab Ordering Cloud, as well as diagnostic industry trends. Read More
Lessons from Operation Warp Speed could benefit future drug discovery
What lessons can the biotech industry learn from Operation Warp Speed? In an interview with, Debrah Thompson, PhD, of HTG Molecular Diagnostics, discusses how the success of the COVID-19 vaccine rollout could benefit the drug discovery process going forward. Read More
Cell and gene therapy sector remains strong despite challenges: ARM CEO
The cell and gene therapy sector is “quite strong” despite the regulatory, investment, and manufacturing challenges facing the industry, according to Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM). Lambert spoke with about developments in the industry. Read More
Machine Bio seeks to fundamentally change how biotechs make protein
Protein purification is one of the biggest bottlenecks for biotechnology companies. However, startup Machine Bio is developing a next-generation protein synthesis platform that can produce pure protein from DNA in hours, minutes, or continuously using a single step process. Founders David Marash and Jack Fernandes spoke with at the 2022 Biotechnology Innovation Organization International Convention. Read More
How one CDMO is navigating the global supply chain disruption
The COVID-19 pandemic has disrupted supply chains and production schedules around the world, forcing contract development and manufacturing organizations (CDMOs) to adapt. In a video interview at the 2022 Biotechnology Innovation Organization International Convention, Federico Pollano of Rentschler Biopharma discussed how the company is navigating the worldwide supply chain disruption. Read More
A case study on partnering between patient advocacy organizations and biotech
Last week's 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego gave patient advocacy organizations and biotech companies the first opportunity in three years to meet in person with the potential for partnering. However, it was a meeting at BIO 2019 between CMT Research Foundation and DTx Pharma that could serve as a model for such partnerships. Read More
NIH seeks industry partners for technology transfer
The National Institutes of Health (NIH) is the world’s largest public funder of biomedical research. spoke with Michael Salgaller of the National Cancer Institute at the 2022 Biotechnology Innovation Organization International Convention about NIH’s technology transfer professionals who work with its scientist inventors to find commercial partners to take their inventions to market. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter